• SNORA38B Drives NSCLC Progression and Alters Immunotherapy R

  2026-04-30

  This study identifies SNORA38B as a key oncogenic snoRNA in non-small cell lung cancer (NSCLC), promoting tumor growth and immune suppression through the GAB2/AKT/mTOR pathway. Targeting SNORA38B with locked nucleic acids sensitizes tumors to immune checkpoint blockade, providing a potential new therapeutic target and informing experimental strategies for tumor microenvironment research.

• Hydroxytyrosol in Research: Protocols, Applications, and Opt

  2026-04-29

  Hydroxytyrosol stands out as a high-purity, phenolic antioxidant compound, providing robust solutions for oxidative stress and cardiovascular health research. This article delivers actionable protocols, troubleshooting strategies, and cross-domain perspectives, empowering scientists to maximize Hydroxytyrosol's translational impact with confidence.

• Thioredoxin System Regulates CHK1 Inhibitor Sensitivity in N

  2026-04-29

  This study uncovers the pivotal role of the thioredoxin (Trx) system in determining the sensitivity of non-small cell lung cancer (NSCLC) cells to CHK1 inhibitors. By linking redox-mediated regulation of ribonucleotide reductase (RNR) to deoxynucleotide pool depletion, the research provides a mechanistic basis for combination therapies targeting redox homeostasis in cancer.

• MDL 28170: Calpain Inhibition for Neurodevelopmental Rescue

  2026-04-28

  Explore how the potent calpain inhibitor MDL 28170 unlocks new avenues in neuroprotection and cognitive rescue research. This article provides a unique, mechanistic analysis backed by the latest literature, highlighting MDL 28170’s translational value in advanced assay design and neurodevelopmental models.

• ECL Chemiluminescent Substrate Detection Kit: Optimized Work

  2026-04-28

  The ECL Chemiluminescent Substrate Detection Kit from APExBIO empowers researchers with ultrasensitive, reproducible HRP-based Western blot chemiluminescence detection. Discover how this kit elevates protein and nucleic acid assays, troubleshoot common issues, and implement data-driven enhancements inspired by recent cancer research breakthroughs.

• EPZ5676: DOT1L Inhibitor Driving Precision in Leukemia Resea

  2026-04-27

  EPZ5676 is redefining epigenetic research workflows with unmatched selectivity in DOT1L inhibition, enabling robust, reproducible results in MLL-rearranged leukemia models. Discover advanced protocol strategies, troubleshooting guidance, and practical insights for maximizing its impact in histone methyltransferase assays.

• Clozapine N-oxide: Precision Control for Neuronal Circuit Re

  2026-04-27

  Clozapine N-oxide (CNO) enables researchers to modulate neuronal activity with exceptional specificity using DREADDs technology. This article unpacks robust experimental workflows, advanced applications, and troubleshooting strategies for CNO in cutting-edge neuroscience, drawing on the latest circuit-specific empathy research.

• Graphene-Induced Apoptosis and Hypoxic Stress in Melanoma Ce

  2026-04-26

  This study demonstrates that graphene film induces intrinsic and extrinsic apoptosis, hypoxic stress, and cell cycle arrest in melanoma cells. The findings reveal the mechanistic underpinnings of graphene's anti-tumor effects, highlighting caspase-3 activity and offering new directions for apoptosis assay design and melanoma research.

• 4-Ethylphenyl Sulfate (SKU B6051): Assay Reliability in Rena

  2026-04-25

  This article addresses common laboratory challenges in cell viability, cytotoxicity, and neurobehavioral assays, highlighting how 4-Ethylphenyl sulfate (SKU B6051) from APExBIO enables reproducible and interpretable data. Integrating scenario-driven Q&A and the latest literature, it guides biomedical researchers in leveraging this high-purity reagent for gut microbiota-brain interaction and renal dysfunction workflows.

• Captopril: ACE Inhibitor Workflows for Hypertension & Oncolo

  2026-04-24

  Captopril stands out as a gold-standard ACE inhibitor for translational research, bridging cardiovascular and oncology models with proven reproducibility. This article details practical workflows, advanced applications in peristalsis and apoptosis, and troubleshooting strategies grounded in recent bradykinin signaling discoveries.

• Plerixafor (AMD3100): Scientific Frontiers in CXCR4 Axis Mod

  2026-04-24

  Explore the advanced scientific landscape of Plerixafor (AMD3100) as a CXCR4 axis inhibitor. This article delivers unique, evidence-backed insights into mechanistic action, assay considerations, and paradigm-shifting research for cancer and hematopoietic stem cell mobilization.

• Applied Strategies Using U-73122: A Phospholipase C Inhibito

  2026-04-23

  U-73122 empowers researchers to dissect PLC-dependent signaling with precision, enabling robust calcium flux inhibition and chemotaxis assays. This guide translates recent mechanistic findings into actionable workflows, troubleshooting, and advanced applications for apoptosis and inflammation research.

• Pomalidomide (CC-4047): Workflow-Driven Advances in Myeloma

  2026-04-23

  Pomalidomide (CC-4047) empowers researchers to dissect tumor microenvironment modulation and drug resistance in multiple myeloma with precision. This guide delivers actionable workflows, troubleshooting strategies, and real-world protocol enhancements for hematological malignancy research.

• Redefining Protein Assay Sensitivity with TCEP Hydrochloride

  2026-04-22

  Discover how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) drives next-generation protein analysis and advanced lateral flow assay innovation. This in-depth article explores unique mechanistic details, protocol parameters, and real-world application insights.

• VX-702: Selective p38α MAPK Inhibitor for Inflammation Resea

  2026-04-22

  VX-702 is a highly selective p38α MAPK inhibitor that provides nanomolar potency and ATP-competitive inhibition, supporting robust suppression of IL-6, IL-1β, and TNFα in preclinical inflammation models. Its validated selectivity and dual-action mechanism make it a preferred tool for dissecting kinase-driven cytokine responses.

452 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page